These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4614898)

  • 1. Clinical trial of isophosphamide (NSC-109724)--results and side effects.
    Bremner DN; McCormick JS; Thomson JW
    Cancer Chemother Rep; 1974; 58(6):889-93. PubMed ID: 4614898
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.
    Ahmann DL; Bisel HF; Hahn RG
    Cancer Chemother Rep; 1974; 58(6):861-5. PubMed ID: 4615785
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacology of isophosphamide.
    Creaven PJ; Allen LM; Alford DA; Cohen MH
    Clin Pharmacol Ther; 1974 Jul; 16(1):77-86. PubMed ID: 4602057
    [No Abstract]   [Full Text] [Related]  

  • 4. A phase 2 study of intermittent high dose isophosphamide therapy of advanced colorectal cancer.
    Kovach JS; Schutt AJ; Hahn RG; Reitemeier RJ; Moertel CG
    Oncology; 1974; 29(1):34-9. PubMed ID: 4837137
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal dysfunction after treatment with isophosphamide (NSC-109724).
    DeFronzo RA; Abeloff M; Braine H; Humphrey RL; Davis PJ
    Cancer Chemother Rep; 1974; 58(3):375-82. PubMed ID: 4842666
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide.
    O'Connell TX; Berenbaum MC
    Cancer Res; 1974 Jul; 34(7):1586-91. PubMed ID: 4833912
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
    Norpoth K; Witting U; Rauen HM
    Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of ifosfamide in the treatment of malignant neoplasms].
    Czownicki Z; Utracka B; Till A; Styrna M
    Nowotwory; 1973; 23(3):285-90. PubMed ID: 4757587
    [No Abstract]   [Full Text] [Related]  

  • 9. New drugs on the horizon in bronchogenic carcinoma.
    Carter SK
    Cancer; 1972 Nov; 30(5):1402-9. PubMed ID: 4117256
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose cyclophosphamide (NSC-26271) for the treatment of metastatic testicular neoplasms.
    Buckner CD; Clift RA; Fefer A; Funk DD; Glucksberg H; Neiman PE; Paulsen A; Storb R; Thomas ED
    Cancer Chemother Rep; 1974; 58(5 Pt 1):709-14. PubMed ID: 4609599
    [No Abstract]   [Full Text] [Related]  

  • 11. Operative and cytostatic treatment of germinal tumours of the testis.
    Vahlensieck W; Weissbach L
    Int Urol Nephrol; 1973 Jan; 5(1):85-95. PubMed ID: 4358874
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
    Kline I
    Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
    [No Abstract]   [Full Text] [Related]  

  • 13. Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.
    Kline I; Gang M; Woodman RJ; Cysyk RL; Venditti JM
    Cancer Chemother Rep; 1973; 57(3):299-304. PubMed ID: 4751256
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and metabolic behavior of the suggested active species of isophosphamide having cytostatic activity.
    Takamizawa A; Matsumoto S; Iwata T; Tochino Y; Katagiri K
    J Med Chem; 1974 Nov; 17(11):1237-9. PubMed ID: 4416021
    [No Abstract]   [Full Text] [Related]  

  • 15. A two-stage therapeutic design in the spontaneous AKR lymphoma system.
    Goldberg AI; Glynn JP; Kende M; Mantel N; Goldin A
    Cancer Res; 1972 Jun; 32(6):1321-8. PubMed ID: 4113146
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of ifosfamid with cyclophosphamide in the therapy of rat DS carcinosarcoma].
    von Ardenne M; Reitnauer PG; Rohde K
    Arch Geschwulstforsch; 1971; 38(1):15-26. PubMed ID: 4334130
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppressive properties of cyclophosphamide analogues.
    Harrison EF; Fuquay ME
    Proc Soc Exp Biol Med; 1972 Mar; 139(3):957-63. PubMed ID: 5063370
    [No Abstract]   [Full Text] [Related]  

  • 18. Bronchogenic carcinoma: new drugs available for study.
    Slavik M; Carter SK
    Cancer Chemother Rep 3; 1973 Mar; 4(2):265-9. PubMed ID: 4125744
    [No Abstract]   [Full Text] [Related]  

  • 19. Isophosphamide as a new acrolein-producing antineoplastic isomer of cyclophosphamide.
    Alarcon RA; Meienhofer J; Atherton E
    Cancer Res; 1972 Nov; 32(11):2519-23. PubMed ID: 5082597
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical conference: facial paralysis. Grand rounds. Massachusetts Eye and Ear Infirmary.
    Schuknecht H; Goodman ML; Weber A; Pappanikou A; Tolpin D
    Ann Otol Rhinol Laryngol; 1974; 83(2):257-63. PubMed ID: 4817439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.